Research article · 10 Apr 2024
Research articlePublished 3 Aug 2017
Clinical Factors Associated with the Risks of Depression in Patients with Parkinsons Disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: Depression is twice as common among patients with Parkinson’s disease (PD) than it is among healthy individuals, and treating the symptoms of depression could help improve the quality of life of patients. A better understanding of the factors associated with depression can lead to a focused screening and clinical examination/interview of this patient population. Methods: This study enrolled 93 adult patients with idiopathic PD aged ≥ 55 years. The severity of depression was classified as follows using the Geriatric Depression Scale (GDS) score: No depression (GDS, 0-9), mild depression (GDS, 10-19), and severe depression (GDS, 20-30). Stepwise logistic regression was then used to evaluate the relationships between baseline clinical factors and the presence of depression (both mild and severe depression), after adjusting for potential confounding factors. Results: In total, 73 (78%) patients with PD were diagnosed with depression (mild depression, n=51; severe depression, n=22). Clinical factors associated with the risk of depression were sex, years of education, exercise habituation, mini‐mental state examination (MMSE) scores, mean levodopa equivalent dose, and mean Barthel index, unified Parkinson’s disease rating scale (UPDRS) score, striatal dopamine transporter uptake ratios, and Hoehn and Yahr staging. Of these risk factors, both female sex and mean UPDRS score remained independently associated with the risk of depression in the stepwise logistic regression analysis. Women had an odds ratio of 3.6 compared to that of men, and the cut-off value of the mean UPDRS score for predicting the risk of depression was 38.5 (sensitivity, 75%; specificity, 76.5%). Conclusion: Higher mean UPDRS score (>38.5) and female sex are associated with a higher risk of depression. The prevention and evaluation of depressive disorders in the high-risk PD group are important safety issues and are highly relevant to patients’ quality of life.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Neuropsychiatry.
Research article · 24 Jan 2024
Insomnia Insights: A Retrospective Study of Sleep Patterns at Kuwait Centre for Mental Health over 16 years.
Commentary · 26 Dec 2023
Assessing the Impact of Eating and Sleep Disorders on Health
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNeuropsychiatry
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Hsiao-Ching Shao”
- BylineArticles whose byline prints “Chao Tung Chen”
- BylineArticles whose byline prints “Wei-Che Lin”
- BylineArticles whose byline prints “Hsueh-Wen Chang”
- BylineArticles whose byline prints “Kuei-Yueh Cheng”
- BylineArticles whose byline prints “Wen-Neng Chang”
- BylineArticles whose byline prints “Nai-Wen Tsai”
- BylineArticles whose byline prints “Chih-Cheng Huang”